Do you want to read an article? Please log in or register.
Long-term efficacy, tolerability, and retention of brivaracetam in epilepsy treatment: A longitudinal multicenter study with up to 5 years of follow-up
Epilepsy
Related content
Epilepsy
Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Epilepsia.
O'Brien TJ, Borghs S, He QJ, Schulz AL, Yates S, Biton V
doi: 10.1111/epi.16484.
Epilepsy
Long-term efficacy of add-on stiripentol treatment in children, adolescents, and young adults with refractory epilepsies: A single center prospective observational study
Epilepsia.
Rosati A, Boncristiano A, Doccini V, Pugi A, Pisano T, Lenge M, De Masi S, Guerrini R
doi: 10.1111/epi.16363.
Migraine and Headache
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
J Headache Pain.
Blumenfeld AM, Stark RJ, Freeman MC, Orejudos A, Manack Adams A
doi: 10.1186/s10194-018-0840-8.
Epilepsy
Surgical Treatment of Nonlesional Neocortical Epilepsy: Long-term Longitudinal Study
JAMA Neurol.
Kim DW, Lee SK, Moon HJ, Jung KY, Chu K, Chung CK
doi: 10.1001/jamaneurol.
Epilepsy
Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany
Epilepsia.
Steinig I, von Podewils F, Möddel G, Bauer S, Klein KM, Paule E, Reif PS, Willems LM, Zöllner JP, Kunz R, Runge U, Kurlemann G, Schubert-Bast S, Rosenow F, Strzelczyk A
doi: 10.1111/epi.13768.
RECOMMENDED
Migraine and Headache
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)
Cephalalgia.
Brandes JL, Klise S, Krege JH, Case M, Khanna R, Vasudeva R, Raskin J, Pearlman EM, Kudrow D
doi: 10.1177/0333102419864132.
Epilepsy
Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studies
Epilepsia.
Rektor I, Krauss GL, Inoue Y, Kaneko S, Williams B, Patten A, Malhotra M, Laurenza A, Wechsler RT
doi: 10.1111/epi.16573.
Epilepsy
Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307
Epilepsia.
Krauss GL, Perucca E, Kwan P, Ben-Menachem E, Wang XF, Shih JJ, Patten A, Yang H, Williams B, Laurenza A
doi: 10.1111/epi.14044.
Epilepsy
Long-term treatment of epilepsy with everolimus in tuberous sclerosis.
Neurology.
Krueger DA, Wilfong AA, Mays M, Talley CM, Agricola K, Tudor C, Capal J, Holland-Bouley K, Franz DN